Abstract

Burn injury is debilitating and among one of the most frequently occurring traumas. Critical care improvements have allowed for increasingly positive outcomes. However, infection, whether it be localized to the site of the wound or systemic in nature, remains a serious cause of morbidity and mortality. Immune suppression predisposes the burn population to the development of invasive infections; and this along with the possibility of inhalation injury puts them at a significant risk for mortality. Emerging multi-drug-resistant pathogens, including Staphylococcus aureus, Enterococcus, Pseudomonas, Acinetobacter, Enterobacter, and yeast spp., continue to complicate clinical care measures, requiring innovative therapies and antimicrobial treatment. Close monitoring of antimicrobial regimens, strict decontamination procedures, early burn eschar removal, adequate wound closure, proper nutritional maintenance, and management of shock and resuscitation all play a significant role in mitigating infection. Novel antimicrobial therapies such as ultraviolet light, cold plasma and topical antiseptics must continue to evolve in order to lower the burden of infection in burn.

Highlights

  • Despite significant improvement in the morbidity and mortality associated with burn injuries, infection remains one of the most common and serious complications in the care of the burn patient [1,2]

  • In order to minimize infection, clinical interventions have focused on early burn excision and grafting, novel wound dressings, adequate ventilation and hemodynamic support, improved nutrition, and suitable antibiotic administration [3,4,5,6]

  • Recognizing infection and recognizing it early enough to prevent progression to sepsis form a critical facet of burn patient care

Read more

Summary

Introduction

Despite significant improvement in the morbidity and mortality associated with burn injuries, infection remains one of the most common and serious complications in the care of the burn patient [1,2]. In order to minimize infection, clinical interventions have focused on early burn excision and grafting, novel wound dressings, adequate ventilation and hemodynamic support, improved nutrition, and suitable antibiotic administration [3,4,5,6]. Burn wound infections complicate 1.8% of all burn admissions and urinary tract infections, cellulitis and pneumonia are the most common fatal infections [2,7,9]. Minimizing risk factors and maximizing the patient’s ability to stave off fatal infections require a truly multi-disciplinary effort

Risk Factors for Infection
Pathophysiology of the Burn Wound
Diagnosis of Infection and Sepsis
Streptococcus
Enterococcus
Acinetobacter
Enterobacter
Fungi and Yeasts
Viruses
Specific Infections in the Burn Patient
Pneumonia
Phage Therapy
Minimizing Contamination
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.